Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tacrolimus after rATG and infliximab induction immunosuppression (RIMINI)

Next Previous
Trial Profile

Tacrolimus after rATG and infliximab induction immunosuppression (RIMINI)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 03 Aug 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Antithymocyte globulin (Primary) ; Infliximab (Primary) ; Prednisolone (Primary) ; Tacrolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Acronyms RIMINI

Most Recent Events

  • 08 Jun 2022 Primary endpoint has been met. (1) Composite endpoint of efficacy failure of the induction regimen defined as occurrence of any of the following individual outcomes up to 12 months post transplantation (start of follow up at transplantation): acute rejection, graft loss or poor graft function defined as eGFR40 ml/min.)
  • 08 Jun 2022 Results presented at the 2022 American Transplant Congress
  • 19 Mar 2022 This trial has been completed in Spain (Global End Date: 31 Dec 2020), according to European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top